Use of Intravenous Proton Pump Inhibitors in Community Practice: An Explanation for the Shortage?
Authors:
- 1 July 2004
- journal article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 99 (7) , 1233-1237
Abstract
Since 2001, one intravenous proton pump inhibitor (pantoprazole) has been available in the United States. A drug shortage bulletin was issued for this agent in 2003. To evaluate the patterns of use of intravenous proton pump inhibitors (IV PPIs) in routine clinical practice. Prospective evaluation of IV PPI use in two community-based teaching hospitals. A computerized pharmacy ordering system was used to identify all patients for whom an IV PPI was ordered. Trained investigators obtained clinical data from patient records and these data were mapped to establish clinical criteria for the use of IV PPIs. Intravenous PPIs were prescribed in 238 patients over a 30-day period and a total of 1,631 doses were prescribed. Primary care providers prescribed 46% of prescriptions. Fifty-six percent of patients who received IV PPIs had no acceptable indication for their use. Of the 126 (81%) patients who were started on PPIs for the first time during their hospital stay, 102 were discharged on a PPI. Intravenous PPIs are widely used for poor indications, which may contribute to the shortage of these agents.Keywords
This publication has 12 references indexed in Scilit:
- Intravenous pantoprazole (IVP) and continuous infusion cimetidine (C) prevent upper gastrointestinal bleeding (UGIB) regardless of APSII score (APACHE II) in high risk intensive care unit (ICU) patientsGastroenterology, 2003
- Cost-effectiveness analysis of high-dose omeprazole infusion as adjuvant therapy to endoscopic treatment of bleeding peptic ulcerGastrointestinal Endoscopy, 2003
- Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategiesAmerican Journal of Gastroenterology, 2003
- Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenouslyAmerican Journal of Gastroenterology, 2001
- Effect of Intravenous Omeprazole on Recurrent Bleeding after Endoscopic Treatment of Bleeding Peptic UlcersNew England Journal of Medicine, 2000
- A Prospective Study of Omeprazole Suspension to Prevent Clinically Significant Gastrointestinal Bleeding from Stress Ulcers in Mechanically Ventilated Trauma PatientsThe Journal of Trauma: Injury, Infection, and Critical Care, 1998
- A Prospective Randomized Comparative Trial Showing That Omeprazole Prevents Rebleeding in Patients With Bleeding Peptic Ulcer After Successful Endoscopic TherapyArchives of internal medicine (1960), 1998
- Effect of repeated boluses of intravenous omeprazole and primed infusions of ranitidine on 24-hour intragastric pH in healthy human subjectsDigestive Diseases and Sciences, 1995
- Risk Factors for Gastrointestinal Bleeding in Critically Ill PatientsNew England Journal of Medicine, 1994
- Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial.BMJ, 1992